Adjust this to 9.00 for the three days after the time change
showed that GLP-2 administered subcutaneously (s.c.) in doses ranging from 200, 400, and 800 g in healthy postmenopausal women dose-dependently reduced bone resorption (measured as CTX), while the bone formation (measured as osteocalcin) was unaffected (7)
But is taking a fraction of the dose actually safe or just a risky shortcut
When to Discuss a Dosage Change You may need to review your dosage with your provider if: You experience persistent swelling, numbness, or tingling IGF-1 or glucose levels move outside your target range Youre not seeing expected results after several months of consistent use Providers may adjust the timing, switch formulations, or combine tesamorelin with peptides such as CJC-1295 or Ipamorelin for synergistic effects
[1] These animal-model results should remain limited to the reported preclinical setting
What GLP-1 ones do is they've created a synthetic version of the fullness hormone